Topical Ankaferd Blood Stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization.
Turhan
Nesrin
N
Kurt
Mevlut
M
Shorbagi
Ali
A
Akdogan
Meral
M
Haznedaroglu
Ibrahim Celalettin
IC
D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D000328:Adult; D000368:Aged; D001707:Biopsy, Needle; D003082:Colectomy / Q000379:methods; D003111:Colonic Polyps / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D003113:Colonoscopy; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000517:prevention & control*; D010936:Plant Extracts; D011300:Preoperative Care / Q000379:methods; D012007:Rectum; D016896:Treatment Outcome
D006490:Hemostatics; D010936:Plant Extracts; C539751:ankaferd blood stopper